SCHEMBL6403474

SCHEMBL6403474

COc1ccccc1-c1nnc(SCCSc2nnc(-c3ccccc3OC)n2-c2ccc(C)cc2)n1-c1ccc(C)cc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.73
CYP2C19 P33261 2/20 0.73
HTT P42858 1/20 0.57
KMT2A Q03164 2/20 0.56
TP53 P04637 2/20 0.55
ALDH1A1 P00352 4/20 0.55
TSHR P16473 3/20 0.55
LMNA P02545 1/20 0.55
SMN1; SMN2 Q16637 2/20 0.53
MAPK1 P28482 1/20 0.53
CNR2 P34972 1/20 0.53
MAPT P10636 1/20 0.50
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
USP2 O75604 1/20 0.47
HPGD P15428 1/20 0.47
KDM4E B2RXH2 2/20 0.47
MEN1 O00255 1/20 0.47
CYP1A2 P05177 1/20 0.47
GAA P10253 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL930747 0.80 CYP3A4 (0.57) CYP3A4CYP2C19HTTKMT2ATP53
SCHEMBL5717657 0.79 ALDH1A1 (0.76) CYP3A4CYP2C19HTTKMT2ATP53
SCHEMBL5717661 0.77 TP53 (0.70) CYP3A4CYP2C19HTTKMT2ATP53
SCHEMBL11919906 0.76 TP53 (0.82) CYP3A4TP53SMN1; SMN2MAPTGAA
SCHEMBL13048281 0.75 TP53 (0.69) CYP3A4KMT2ATP53ALDH1A1LMNA
SCHEMBL6402376 0.74 TSHR (0.50) CYP3A4CYP2C19KMT2ATP53ALDH1A1
SCHEMBL4215755 0.73 ALDH1A1 (0.65) CYP3A4CYP2C19HTTKMT2AALDH1A1
SCHEMBL6405743 0.73 CYP3A4 (0.69) CYP3A4CYP2C19HTTKMT2ATP53
SCHEMBL4197785 0.72 KMT2A (0.56) CYP3A4CYP2C19HTTKMT2AALDH1A1
SCHEMBL6247799 0.72 KMT2A (1.00) CYP3A4CYP2C19HTTKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof AGRIUS GROUP, LLC. 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof ABCG2, ATP5ME, DNTT CYP3A4 25/4885CYP2C19 142/4885HTT 2113/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.